|
|
|
市場調查報告書
美國醫學實驗室業界（第10版）
The U.S. Medical Laboratories Industry (10th Edition)
|
美國醫學實驗室業界（第10版） 是由出版商MarketData Enterprises, Inc.在2010年04月所出版的。
這份英文市場調查報告書包含230 pages, 113 Tables & Charts 價格從美金2195起跳。
美國的臨床實驗室商務在受到不景氣的嚴重打擊之中，由於高齡化與新型試験的開發等因素而被認為到2013年都將會擴大。
本報告書為主要實驗類別的業界動向與發展，包含各類別1980∼2008年成績與2013年為止的預測資料，概述如下。
總綱：業界概要
市場規模・成長・市場區分
- 業界規模
- 政府所做的調査
- 競爭動向
- 市場資料：1993∼2008年與2009∼2013年
- 各實驗類別動向
- 供應商的市場佔有率
主要實驗室市場
醫局實驗室
商用實驗室業界的構造與運作率
工作者：給薪・求人率・離職者
- 2008年調査結果
- medical Lab Observer Magazine之調査
企業簡介：業界龍頭的競爭動向
- AmeriPath
- Associated Regional & University Pathologists
- Bio-Reference labs
- Clinical Pathology Labs
- Laboratory Corp. of America Holdings
- Mayo Medical Laboratories
- Quest Diagnostics
- Spectrum Laboratory Network
- Sonora Quest Laboratories
業界情報源的參考目錄
Abstract
This best-selling Marketdata study is a comprehensive analysis of the
fragmented but sizeable $57 billion U.S. clinical lab testing business. The
industry was hurt by the recession but is poised for moderate growth to 2013,
as the U.S. population ages and new tests are developed. Higher margin
esoteric and anatomic pathology tests are pacing growth and the large chains
have made a string of acquisitions in this space, to “buy” growth.
International expansion could be the next growth frontier.
The study examines, in detail, recent industry trends and developments in the
major test segments: PAP tests, workplace drug screening, and esoteric tests.
An entire chapter is devoted to the high-growth $6.6 billion
“esoteric” or reference test market - its size, growth, nature,
profiles of all key competitors, with revenue rankings.
Complete analysis of independent commercial labs, hospital labs, and physician
office labs - how they differ and compete, discussion of major industry trends
and demand factors, extensive national/state operating ratios/latest Census
and CLIA data. Analysis of industry receipts from 1980-2008 actual, 2009
performance and 2010 outlook, 2013 forecasts, lab staff salaries and vacancy
rates, insurance industry testing, latest trade journal survey findings.
Estimates and opinions of multiple brokerage firms. Competitor profiles for:
Quest Diagnostics, Lab Corp. of America Holdings, Bio-Reference Labs, American
Esoteric Labs, Ameripath, ARUP, Genzyme, Medtox Scientific, Clinical Pathology
Labs, Mayo Medical Labs, Spectrum Lab Network, Sonora Quest Labs, and more.
Contains reference directory of industry sources, list of NIDA-certified drug
test labs. This study contains 113 tables and charts, and is also sold by
chapters. It is available via several commercial databases as well.
Total: 230 pages; 113 Tables & Charts.
Table of Contents
Introduction: Report Scope & Methodology
Executive Overview of The Industry: Major Findings
Nature & Characteristics of The Industry: Discussion of industry
characteristics, influence of government agencies, routine vs. esoteric tests,
in-hospital, commercial and physician-office labs, how tests are processed,
lab facilities (regional labs, sales ports, collecting stations, etc.),
industry structure, lab marketing and advertising practices.
- Highlights of ALL chapters: Discussion of 2007-2009 key industry trends &
developments, discussion of industry consolidation, market size (1993-2008
actual, 2009-2010 estd., 2010-2013 forecasts), share of mkt. by hospitals,
commercial labs, POLs, home test mkts., size/outlooks for the major test mkts.
(Pap tests, drug tests), nature/size of esoteric test mkt. industry structure
& key operating ratios of medical labs, industry profitability. Includes
tables, opinions of brokerage analysts, industry consultants, recent
legislative developments.
Market Size, Growth, Market Segments
- Discussion of industry size as estimated by: brokerage firm analysts,
major lab chains, consulting firms, government sources - merits/limitations of
each.
- Government Census: commercial lab receipts (1980-2008), annual percent
changes, analysis
- Competitor & brokerage analyst estimates of industry size, comparison,
discussion (1999-2007), receipts as % total health care expenditures
- Marketdata estimates of industry size: 1993-2008, industry demand factors,
effects of recession, forecast for 2009-2013 for lab receipts & healthcare
expenditures
- Industry receipts by test segment (routine, esoteric, anatomic pathology
(1999-2009, 2010-2013 projections, in dollars and as % total industry)
- Major test segments, receipts as % of total industry: 1999-2013F
- Major test provider share of industry sales: breakdown by: hospital labs,
independent commercial labs, physician office labs, other (1999-2009, $ and %
of total, 2013 projections)
THE MAJOR LAB TEST MARKETS:
The Pap Smear Test Market
- Summary of Pap screening, evolution of guidelines from 1990s to date
- Analysis of new technologies boosting growth of this segment: Cytyc' s
ThinPrep test vs. AutoPap test by Tripath Imaging, DNA Pap test by Digene, etc.
- Profiles/descriptions & Revenues of Hologic (Cytyc), Digene, Tripath
Imaging-( 2009/2008 Revenues)
- Demographics of users: results of Prevention Index survey (frequency of
testing: 1987-95, demographics), Natl. Health Interview Survey (demographic
profile of women tested)
- Market Size: Marketdata & competitor estimates of no. of tests performed
and $ value, historical and current year, growth rate, avg. prices,
- Who performs Pap tests?, public vs. private sector (Planned Parenthood
tests 1986-2007
- Discussion: Can existing professionals handle the work volume? No. of
cytology training programs, rebound since 1988, salaries/vacancy rate of
cytotechs, daily workload limits, recent reforms, discussion of past error
rates, poor work/screening practices
The Workplace Drug Testing Market
- Estimated cost of drug abuse in the U.S. workplace, societal costs
- Size/growth rate of testing, no. of tests done, scope of drug testing in
U.S. today, estimated no. of workers tested, transportation workers (NIDA,
trade journals opinions, AMA)
- Types of drug tests used (urine, blood, hair), shift to hair and saliva
analysis - discussion of new emerging tests, changes in Federal testing
planned (SAMHSA)
- Trends in drug use: latest 2008 findings of Quest Drug Testing Index
(1988-2008), decline in amphetamine usage, test positive rate trends
- Table: annual positivity rates for U.S. workforce: 1988-2008
- Table: positivity rates, by type drug: 2002-2008, by testing reason:
2002-2008
- Market size: Marketdata estimates of drug test mkt. $ value,/growth for
1989-2009, demand, outlook to 2013 F-negative effects of a recession and
hiring on mkt., reasons for flat growth, major competitors involved, avg. test
costs
- Table: Estd. Revenues of the top 5 drug testing companies: 2004-2008
- The home drug test market. Nature of, Mkt. size estimates, Phamatech,
First Check
- Testing by the insurance industry: Discussion of Lab One, Clinical
Reference Labs, Osborn Labs - estimated shares of market, mkt. size in $
- Major findings of AMA Drug Testing Survey (2004 is latest): prevalence of
testing, by corporations, testing of current employees, new hires,
test-positive rates, employer actions, avg. cost per employee, effectiveness,
testing methods used, etc.
- 2004 AMA survey results: workplace medical testing, 1997-2003 trends:
tables for... testing rates by companies for new hires/current workers,
reasons for drug testing, historical dat
- The private sector - worker privacy issues, court rulings, random testing,
state policies
- The public sector - DOT/transportation worker testing (regulated
industries): labs qualified by SAMHSA, certification requirements
- List: Name, address, phone no. of the 48 labs certified by NIDA for
federal testing.
- Competitor Profiles (in-depth descriptions, estd. and actual drug test
revenues, etc.) for: Quest Diagnostics, Lab Corp. of America (and LabOne),
Medtox Scientific. (2008 revenues)
The Esoteric Test Market
- Discussion of what defines esoteric vs. routine tests, no. of labs
performing, major trends emerging , discussion of Medicare reimbursement
- Coverage of latest mkt. developments, constraints & positives for growth
- Competitor & brokerage analyst estimates of esoteric vs. routine, other
test segments
- Discussion of Genzyme Genetics report re genetic testing mkt. (2001-2005)
- Market size/growth: sources of data (The Dark Report, Lab Industry Report,
Genzyme, Marketdata research, estimates), analysis of mkt. $ size and
rationale for estimates. Analysis of growth - 2000-2009 mkt. size estimate,
2010 & 2013 forecasts.
- Ranking of top companies in the market: 2006 vs. 2009 (Marketdata
estimates or actual sales),
- The 7 main classes of esoteric tests (oncology, immunology, toxicology,
genetics, hematology, etc.)
Tables
- Industry receipts, by: routine, anatomic pathology, esoteric: 1999-2013F
($ and % of total)
- Esoteric tests, by kind: $ receipts 2003, 2005, 2009 (endocrinology,
genetics, immunology, infectious disease, oncology, serology, toxicology)
Competitor Profiles
- (address, capabilities, specialties, no. of tests performed, revenues-when
available) for: ARUP, American Esoteric Labs/Sonic Healthcare, Bio-Reference
Labs, Clinical Pathology Labs, Genzyme, LabCorp of America (Esoterix, Dianon,
Viroed, Dynacare), Mayo Medical Labs, Medtox Scientific, Quest Diagnostics
(AML, Ameripath, Unilab, LabOne) - 2004-2009 revenues.
Physician-Office Labs
Discussion of estimated number in U.S., growth/decline, regulations that have
cut their share of industry revenues, estd. current share of industry receipts
in 2009 effects of CLIA on group practices, historical investigations about
overuse of lab tests, conflicts of interest, debates, etc. Brokerage firm
estimates.
Tables:
- No. of POLs, by lab type (2009 CMS data)
- POLs, by CLIA certification type (2006)
- No. of labs, by type/location of facility (2009 CMS data)
- No. of all labs and POLs, CLIA registered: 1993-2009
- POLs, by application type: 1995-2005
- Annual receipts and avg. receipts per POL: 1999-2006, projected 2007-2013
Structure & Operating Ratios Of The Commercial Lab Industry
Discussion of 2007Census data- data available so far, status of reporting &
Industry snapshot: 1987-2007, key ratios Summary and discussion of key
findings: no. of US labs, 1982-2007 20-year industry ratios summary, single
vs. multi-unit operations, legal form of organization, ratios by receipts size
of company & establishment (lab), top 50 firm' s mkt. share levels, geographic
analysis/receipts by state (1997 vs. 2002 Census data), financial
health/composite industry balance sheet ratios
Tables:
- 20-year summary of industry structure: 1987-2007
- Medical labs' sources of revenue, by kind: 2006-2008
- Non-employer stats. For 2002, receipts, by legal form of company
- Medical labs, by legal form of organization: 2002, 1997 & 1992
(corporation, individual proprietorship, partnership, etc.)
- Industry concentration ratios: 2002, 1997 & 1992
- Medical labs, by annual receipts size of FIRMS: 2002, 1997 & 1992, (no. of
firms, labs, receipts, as % total industry)
- Medical labs, by receipts size of FIRMS (under $100,000/yr.-$100+ mill.):
2002, 1997 & 1992, receipts, annual payroll as % receipts, no. of employees)
- Medical labs, by receipts size of ESTABLISHMENTS (under $10,000/yr.-$10+
mill.): 2002, 1997 & 1992, receipts, annual payroll as % receipts, no. of
employees)
- Labs' ratios (as above) by single vs. multi-unit operations: 2002, 1997 &
1992
- No. of medical labs, by state: 1997 vs. 2002 vs. 2007
- No. and receipts of labs, avg. receipts per lab, by state: 1997 vs. 2002
- Receipts of medical labs, ranked by state (1992, 1997, 2002)
- No. & receipts of non-employer labs, by state: 2007
- Composite financial statement for medical labs as a group- average balance
sheet & income statement/key ratios: 2005-2009
Lab Staff Issues: Salaries, Vacancy Rates, Turnover
- Results of 2008 ASCP/Lab Medicine Magazine Survey:
- Discussion of hourly wages and % increases in beginning/avg. pay scales:
medical technologists, cytotechs, histologic techs, ML techs, phlebotomists,
national data: 2000-2005 comparisons.
- U.S. Bureau of Labor Statistics data: employment of lab
techs/technologists: 2000-2008, no. employed and avg. annual income, 2007-2014
projections
- ASCP 2008 Wage & Vacancy survey, major findings
- Medical Technologists & Medical Technicians employment & mean income
(2000-2008)
- Table: Avg. hourly wages, by 12 lab staff positions: 2003, 2005
- Table: Vacancy rates, by 12 lab positions: 2000-2008
- Table: No. of month to fill vacant positions
- Summary of ASCT salary survey, 2008, cytotech vs. other positions, yearly
salaries
- Table: Hourly salary range, by lab position
- Table: Hourly salaries, by region
- Table: No. of cytotech vacancies per lab
- Table: No. of years in the field, in current position, in current lab.
Medical Lab Observer Magazine 2003-2009 survey highlights:
- Summary & discussion of, tables for:
- Annual salary, medians: 2003-2009, by 7 job types, staff & supervisory
- Annual salary, medians: 2003-2009, by region
- Annual salary, medians: 2003-2009, by education
- Annual salary, medians: 2003-2009, by years in the field
- Discussion of medical lab staff training programs
Tables:
- no. of accredited cytotechnology programs: 1976-2000
- grads from accredited programs: 2001-2004, annual increase in workforce
- projected yearly increase in medical lab techs 2005 to 2014
Company Profiles - The Top Industry Competitors
(For most companies below: historical development of firm, kinds of tests
performed, 2006-2009 financial performance, 2010 guidance, divisional
breakdowns and structure, recent mergers, acquisitions or joint ventures,
marketing agreements, company strategies, etc.)
- AmeriPath (Quest)
- Associated Regional & University Pathologists
- Bio-Reference labs
- Clinical Pathology Labs (Sonic Healthcare)
- Laboratory Corp. of America Holdings
- Mayo Medical Laboratories
- Quest Diagnostics
- Spectrum Laboratory Network
- Sonora Quest Laboratories
Reference Directory Of Industry Information Sources
(Lab industry trade associations, trade journals, consulting firms, government
agencies, special reports and surveys, stock analysts, etc.), address, phone,
key contacts
|
 |
